Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghoshd D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM.

Eur Urol. 2010 Sep;58(3):e29-30; author reply e31-2. doi: 10.1016/j.eururo.2010.05.003. Epub 2010 May 18. No abstract available.

PMID:
20537788
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

Hewavitharana AK.

Eur Urol. 2010 Oct;58(4):e39-40; author reply e41-2. doi: 10.1016/j.eururo.2010.07.031. Epub 2010 Aug 4. No abstract available.

PMID:
20696519
[PubMed - indexed for MEDLINE]
3.

Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur Urol 2010;58:12-8.

Colleselli D, Stenzl A, Schwentner C.

Eur Urol. 2010 Nov;58(5):e51. doi: 10.1016/j.eururo.2010.08.017. Epub 2010 Aug 18. No abstract available.

PMID:
20728983
[PubMed - indexed for MEDLINE]
4.

Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours.

Jentzmik F, Stephan C, Miller K, Schrader M, Erbersdobler A, Kristiansen G, Lein M, Jung K.

Eur Urol. 2010 Jul;58(1):12-8; discussion 20-1. doi: 10.1016/j.eururo.2010.01.035. Epub 2010 Jan 26.

PMID:
20117878
[PubMed - indexed for MEDLINE]
5.

High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection.

Rogers CG, Gonzalgo ML, Yan G, Bastian PJ, Chan DY, Nelson WG, Pavlovich CP.

J Urol. 2006 Nov;176(5):2280-4.

PMID:
17070312
[PubMed - indexed for MEDLINE]
6.

Promising marker found for deadly prostate cancer.

Kuehn BM.

JAMA. 2009 Mar 11;301(10):1008. doi: 10.1001/jama.2009.299. No abstract available.

PMID:
19278937
[PubMed - indexed for MEDLINE]
7.

Biomarkers. Metabolite in urine may point to high-risk prostate cancer.

Couzin J.

Science. 2009 Feb 13;323(5916):865. doi: 10.1126/science.323.5916.865a. No abstract available.

PMID:
19213886
[PubMed - indexed for MEDLINE]
8.

Sensitive determination of the potential biomarker sarcosine for prostate cancer by LC-MS with N,N'-dicyclohexylcarbodiimide derivatization.

Chen J, Zhang J, Zhang W, Chen Z.

J Sep Sci. 2014 Jan;37(1-2):14-9. doi: 10.1002/jssc.201301043. Epub 2013 Dec 2.

PMID:
24293130
[PubMed - indexed for MEDLINE]
9.

Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis-tandem mass spectrometry.

Soliman LC, Hui Y, Hewavitharana AK, Chen DD.

J Chromatogr A. 2012 Dec 7;1267:162-9. doi: 10.1016/j.chroma.2012.07.021. Epub 2012 Jul 14.

PMID:
22824219
[PubMed - indexed for MEDLINE]
10.

Sarcosine as a marker in prostate cancer progression: a rapid and simple method for its quantification in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry.

Cavaliere B, Macchione B, Monteleone M, Naccarato A, Sindona G, Tagarelli A.

Anal Bioanal Chem. 2011 Jul;400(9):2903-12. doi: 10.1007/s00216-011-4960-0. Epub 2011 Apr 15.

PMID:
21491110
[PubMed - indexed for MEDLINE]
11.

The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population.

Shen M, Chen W, Yu K, Chen Z, Zhou W, Lin X, Weng Z, Li C, Wu X, Tao Z.

Exp Mol Pathol. 2011 Feb;90(1):97-100. doi: 10.1016/j.yexmp.2010.10.009. Epub 2010 Oct 20.

PMID:
20970419
[PubMed - indexed for MEDLINE]
12.

Re: Jean-Nicolas Cornu,Géraldine Cancel-Tassin, Valérie Ondet, et Al. Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis. Eur urol 2011; 59: 197-201.

Lippi G.

Eur Urol. 2011 Oct;60(4):e29; author reply e30. doi: 10.1016/j.eururo.2011.06.030. Epub 2011 Jun 22. No abstract available.

PMID:
21726935
[PubMed - indexed for MEDLINE]
13.

Sarcosine, folate metabolism and prostate cancer--is there a link?

Wagner C, Luka Z.

J Urol. 2011 Feb;185(2):385-6. doi: 10.1016/j.juro.2010.11.019. Epub 2010 Dec 17. No abstract available.

PMID:
21168165
[PubMed - indexed for MEDLINE]
14.

Re: Felix K. Chun, Alexandre de la Taille, Hendrik van Poppel, et al. Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram. Eur Urol 2009;56:659-68.

Morote J.

Eur Urol. 2010 Jan;57(1):e1; author reply e2-3. doi: 10.1016/j.eururo.2009.09.041. Epub 2009 Oct 9. No abstract available.

PMID:
19853371
[PubMed - indexed for MEDLINE]
15.

Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine.

Cao DL, Ye DW, Zhu Y, Zhang HL, Wang YX, Yao XD.

Prostate Cancer Prostatic Dis. 2011 Jun;14(2):166-72. doi: 10.1038/pcan.2011.2. Epub 2011 Feb 15.

PMID:
21321584
[PubMed - indexed for MEDLINE]
16.

Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.

Schostak M, Schwall GP, Poznanović S, Groebe K, Müller M, Messinger D, Miller K, Krause H, Pelzer A, Horninger W, Klocker H, Hennenlotter J, Feyerabend S, Stenzl A, Schrattenholz A.

J Urol. 2009 Jan;181(1):343-53. doi: 10.1016/j.juro.2008.08.119. Epub 2008 Nov 13.

PMID:
19012935
[PubMed - indexed for MEDLINE]
17.

Beyond PSA: will future biomarker tests be better?

[No authors listed]

Mayo Clin Health Lett. 2009 Aug;27(8):4. No abstract available.

PMID:
19757525
[PubMed - indexed for MEDLINE]
18.

GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.

Wu H, Liu T, Ma C, Xue R, Deng C, Zeng H, Shen X.

Anal Bioanal Chem. 2011 Aug;401(2):635-46. doi: 10.1007/s00216-011-5098-9. Epub 2011 May 29.

PMID:
21626193
[PubMed - indexed for MEDLINE]
19.

The role of sarcosine metabolism in prostate cancer progression.

Khan AP, Rajendiran TM, Ateeq B, Asangani IA, Athanikar JN, Yocum AK, Mehra R, Siddiqui J, Palapattu G, Wei JT, Michailidis G, Sreekumar A, Chinnaiyan AM.

Neoplasia. 2013 May;15(5):491-501.

PMID:
23633921
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Is urinary sarcosine useful to identify patients with significant prostate cancer? The trials and tribulations of biomarker development.

Schalken JA.

Eur Urol. 2010 Jul;58(1):19-20. doi: 10.1016/j.eururo.2010.02.025. Epub 2010 Mar 4. No abstract available.

PMID:
20227175
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk